NewAmsterdam Pharma Company N.V. (NAMS)

SEC filing

NewAmsterdam Pharma Company N.V.

NAMS · CIK 1936258

4 · Mar 2, 2026 · Davidson Michael H. sold 443.71K shares at $33.25/share ($14.8M); exercised options for 443.71K shares

Davidson Michael H. sold 443.71K shares at $33.25/share ($14.8M); exercised options for 443.71K shares

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).